BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu NC, Wilson IA. Structural Biology of Influenza Hemagglutinin: An Amaranthine Adventure. Viruses 2020;12:E1053. [PMID: 32971825 DOI: 10.3390/v12091053] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Ng TA, Rashid S, Kwoh CK. Virulence Network of Interacting Influenza-Host Protein Domains.. [DOI: 10.1101/2022.10.11.511722] [Reference Citation Analysis]
2 Zhang L, Chen J, Shen C, Wang G, Lu Z, Zeng D, Gao Y, Chen H, Xia N, Chen Y. Vaccination with Deglycosylated Modified Hemagglutinin Broadly Protects against Influenza Virus Infection in Mice and Ferrets. Vaccines 2022;10:1304. [DOI: 10.3390/vaccines10081304] [Reference Citation Analysis]
3 Achs A, Glasa M, Šubr Z. Plum Pox Virus Genome-Based Vector Enables the Expression of Different Heterologous Polypeptides in Nicotiana benthamiana Plants. Processes 2022;10:1526. [DOI: 10.3390/pr10081526] [Reference Citation Analysis]
4 Zhu X, Han J, Sun W, Puente-Massaguer E, Yu W, Palese P, Krammer F, Ward AB, Wilson IA. Influenza chimeric hemagglutinin structures in complex with broadly protective antibodies to the stem and trimer interface. Proc Natl Acad Sci U S A 2022;119:e2200821119. [PMID: 35594401 DOI: 10.1073/pnas.2200821119] [Reference Citation Analysis]
5 Liu H, Wilson IA. Protective neutralizing epitopes in SARS‐CoV‐2. Immunological Reviews. [DOI: 10.1111/imr.13084] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 West J, Röder J, Matrosovich T, Beicht J, Baumann J, Mounogou Kouassi N, Doedt J, Bovin N, Zamperin G, Gastaldelli M, Salviato A, Bonfante F, Kosakovsky Pond S, Herfst S, Fouchier R, Wilhelm J, Klenk HD, Matrosovich M. Characterization of changes in the hemagglutinin that accompanied the emergence of H3N2/1968 pandemic influenza viruses. PLoS Pathog 2021;17:e1009566. [PMID: 34555124 DOI: 10.1371/journal.ppat.1009566] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Chen Z, Cui Q, Caffrey M, Rong L, Du R. Small Molecule Inhibitors of Influenza Virus Entry. Pharmaceuticals (Basel) 2021;14:587. [PMID: 34207368 DOI: 10.3390/ph14060587] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
8 Keeler SP, Fox JM. Requirement of Fc-Fc Gamma Receptor Interaction for Antibody-Based Protection against Emerging Virus Infections. Viruses 2021;13:1037. [PMID: 34072720 DOI: 10.3390/v13061037] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
9 Puchkova LV, Kiseleva IV, Polishchuk EV, Broggini M, Ilyechova EY. The Crossroads between Host Copper Metabolism and Influenza Infection. Int J Mol Sci 2021;22:5498. [PMID: 34071094 DOI: 10.3390/ijms22115498] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Wilson IA, Stanfield RL. 50 Years of structural immunology. J Biol Chem 2021;296:100745. [PMID: 33957119 DOI: 10.1016/j.jbc.2021.100745] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
11 West J, Röder J, Matrosovich T, Beicht J, Baumann J, Kouassi NM, Doedt J, Bovin N, Zamperin G, Gastaldelli M, Salviato A, Bonfante F, Pond SK, Herfst S, Fouchier R, Wilhelm J, Klenk H, Matrosovich M. Characterization of changes in the hemagglutinin that accompanied the emergence of H3N2/1968 pandemic influenza viruses.. [DOI: 10.1101/2021.04.19.439873] [Reference Citation Analysis]
12 Sempere Borau M, Stertz S. Entry of influenza A virus into host cells - recent progress and remaining challenges. Curr Opin Virol 2021;48:23-9. [PMID: 33838498 DOI: 10.1016/j.coviro.2021.03.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
13 Arista-Romero M, Pujals S, Albertazzi L. Towards a Quantitative Single Particle Characterization by Super Resolution Microscopy: From Virus Structures to Antivirals Design. Front Bioeng Biotechnol 2021;9:647874. [PMID: 33842446 DOI: 10.3389/fbioe.2021.647874] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
14 Sangesland M, Lingwood D. Antibody Focusing to Conserved Sites of Vulnerability: The Immunological Pathways for 'Universal' Influenza Vaccines. Vaccines (Basel) 2021;9:125. [PMID: 33562627 DOI: 10.3390/vaccines9020125] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
15 Li Z, Zhong L, He J, Huang Y, Zhao Y. Development and application of reverse genetic technology for the influenza virus. Virus Genes 2021;57:151-63. [PMID: 33528730 DOI: 10.1007/s11262-020-01822-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
16 Vieira-pires RS, Morgan PM, Choraria A, Gandhimathi C, Michael A, Ôchoa-pires T, Salimian J, Rajan S, Subramani M. Applications of IgY in Human Medicine. IgY-Technology: Production and Application of Egg Yolk Antibodies 2021. [DOI: 10.1007/978-3-030-72688-1_16] [Reference Citation Analysis]